100 related articles for article (PubMed ID: 825451)
21. Reduction of the complement activation capacity of soluble IgG aggregates and immune complexes by IgM-rheumatoid factor.
Doekes G; Schouten J; Cats A; Daha MR
Immunology; 1985 Jul; 55(3):555-64. PubMed ID: 4018839
[TBL] [Abstract][Full Text] [Related]
22. Activation of the first component of human complement, C1, by monoclonal antibodies directed against different domains of subcomponent C1q.
Kilchherr E; Schumaker VN; Phillips ML; Curtiss LK
J Immunol; 1986 Jul; 137(1):255-62. PubMed ID: 3486914
[TBL] [Abstract][Full Text] [Related]
23. Study of the interaction between monoclonal IgM proteins and the complement system.
Füst G; Csécsi-Nagy M; Medgyesi GA; Kulics J; Gergely J
Immunochemistry; 1976 Oct; 13(10):793-800. PubMed ID: 12107
[No Abstract] [Full Text] [Related]
24. Solution structure of human and mouse immunoglobulin M by synchrotron X-ray scattering and molecular graphics modelling. A possible mechanism for complement activation.
Perkins SJ; Nealis AS; Sutton BJ; Feinstein A
J Mol Biol; 1991 Oct; 221(4):1345-66. PubMed ID: 1942055
[TBL] [Abstract][Full Text] [Related]
25. Thermal unfolding of dodecameric glutamine synthetase: inhibition of aggregation by urea.
Nosworthy NJ; Ginsburg A
Protein Sci; 1997 Dec; 6(12):2617-23. PubMed ID: 9416610
[TBL] [Abstract][Full Text] [Related]
26. Studies on the biological functions of monoclonal immunoglobulins and their fragments.
Kraj M; Cieśluk S; Rezmer M; Bragiel I; Snigurowicz J
Arch Immunol Ther Exp (Warsz); 1980; 28(2):297-312. PubMed ID: 7447642
[TBL] [Abstract][Full Text] [Related]
27. C1 fixation and classical complement pathway activation by a fragment of the Cmu4 domain of IgM.
Hurst MM; Volanakis JE; Stroud RM; Bennett JC
J Exp Med; 1975 Nov; 142(5):1322-6. PubMed ID: 1194853
[TBL] [Abstract][Full Text] [Related]
28. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
Brown EJ; Ramsey J; Hammer CH; Frank MM
J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
[TBL] [Abstract][Full Text] [Related]
29. Correlation between the exposure of aromatic chromophores at the surface of the Fc domains of immunoglobulin G and their ability to bind complement.
Isenman DE; Ellerson JR; Painter RH; Dorrington KJ
Biochemistry; 1977 Jan; 16(2):233-40. PubMed ID: 13808
[TBL] [Abstract][Full Text] [Related]
30. Studies on the structural and biological functions of the Cmu4 domains of IgM.
Bubb MO; Conradie JD
Immunology; 1978 Mar; 34(3):449-58. PubMed ID: 417020
[TBL] [Abstract][Full Text] [Related]
31. Effects of limited denaturation by heat on the dynamic conformation of equine immunoglobulin M antibody and on interaction with antigen and complement.
Siegel RC; Cathou RE
Biochemistry; 1981 Jan; 20(1):192-8. PubMed ID: 6781534
[No Abstract] [Full Text] [Related]
32. Binding of the human retrovirus HTLV-III/LAV/ARV/HIV to the CD4 (T4) molecule: conformation dependence, epitope mapping, antibody inhibition, and potential for idiotypic mimicry.
McDougal JS; Nicholson JK; Cross GD; Cort SP; Kennedy MS; Mawle AC
J Immunol; 1986 Nov; 137(9):2937-44. PubMed ID: 2428879
[TBL] [Abstract][Full Text] [Related]
33. A peptide difference between the mu-chains from cell-associated and secreted IgM of the BCL1 tumor.
Yuan D; Uhr JW; Vitetta ES
J Immunol; 1980 Jul; 125(1):40-6. PubMed ID: 6770002
[TBL] [Abstract][Full Text] [Related]
34. Role of antibody and complement in the immune clearance and destruction of erythrocytes. II. Molecular nature of IgG and IgM complement-fixing sites and effects of their interaction with serum.
Schreiber AD; Frank MM
J Clin Invest; 1972 Mar; 51(3):583-9. PubMed ID: 4622104
[TBL] [Abstract][Full Text] [Related]
35. Complement fixation by rheumatoid factor.
Tanimoto K; Cooper NR; Johnson JS; Vaughan JH
J Clin Invest; 1975 Mar; 55(3):437-45. PubMed ID: 1078825
[TBL] [Abstract][Full Text] [Related]
36. Biological properties of chimeric antibodies. Interaction with complement.
Boulianne GL; Isenman DE; Hozumi N; Shulman MJ
Mol Biol Med; 1987 Feb; 4(1):37-49. PubMed ID: 3613975
[TBL] [Abstract][Full Text] [Related]
37. Molecular basis for the temperature-dependent insolubility of cryoglobulins. X. The amino acid sequence of the heavy chain variable region of McE.
Gerber-Jenson B; Kazin A; Kehoe JM; Scheffel C; Erickson BW; Litman GW
J Immunol; 1981 Mar; 126(3):1212-6. PubMed ID: 6780622
[TBL] [Abstract][Full Text] [Related]
38. The effect of specific antibody on antibody-independent interactions between E. coli J5 and human complement.
Betz SJ; Page N; Estrade C; Isliker H
J Immunol; 1982 Feb; 128(2):707-11. PubMed ID: 7033382
[TBL] [Abstract][Full Text] [Related]
39. [The role of the immunoglobin G "hinge" region in heat aggregation and activation of complex-formation].
Khristoforov VS; Persanov VM; Sukhomudrenko AG; Abramov VM; Zav'ialov VP
Biofizika; 1987; 32(1):32-6. PubMed ID: 3493035
[TBL] [Abstract][Full Text] [Related]
40. A conserved disulfide motif in human tear lipocalins influences ligand binding.
Glasgow BJ; Abduragimov AR; Yusifov TN; Gasymov OK; Horwitz J; Hubbell WL; Faull KF
Biochemistry; 1998 Feb; 37(8):2215-25. PubMed ID: 9485367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
